80 studies found for:    Electrocardiogram | Open Studies | NIH, U.S. Fed
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Prevalence of Chagas Disease in Immigrant Patients With Conduction Abnormalities on Electrocardiogram
Condition: Chagas Disease
Intervention: Procedure: Trypanosoma cruzi serology
2 Recruiting Evaluation and Diagnosis of Potential Research Subjects With Traumatic Brain Injury
Condition: Traumatic Brain Injury
Intervention:
3 Recruiting Collection of Lung Fluid and Tissue Samples for Research
Conditions: Mycobacterium Infections, Atypical;   Granulomatous Disease, Chronic;   Job's Syndrome;   Influenza, Human
Intervention:
4 Not yet recruiting Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers
Condition: Opioid-Related Disorders
Interventions: Drug: Naltrexone;   Other: Intravail
5 Recruiting Single Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men
Conditions: Healthy Men;   Male Contraception
Interventions: Drug: Placebo;   Drug: 11βmethyl nortestosterone dodecylcarbonate
6 Recruiting Cardiovascular Disease Screening
Conditions: Congenital Heart Disease;   Atherosclerosis;   Myocardial Ischemia;   Myocardial Infarction;   Acquired Heart Disease
Intervention:
7 Recruiting Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Osteosynthesis Sites
Condition: Bacterial Infection
Interventions: Drug: MBN-101;   Other: Placebo
8 Recruiting Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma
Conditions: Adult Ependymoblastoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Medulloblastoma;   Adult Mixed Glioma;   Adult Oligodendroglial Tumors;   Adult Pineoblastoma;   Adult Supratentorial Primitive Neuroectodermal Tumor (PNET)
Interventions: Radiation: radiation therapy;   Drug: temozolomide;   Drug: plerixafor;   Other: laboratory biomarker analysis;   Other: pharmacological study
9 Recruiting Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
Conditions: Heart Failure, Congestive;   Death, Sudden, Cardiac;   Arrhythmia;   Cardiomyopathies
Intervention:
10 Recruiting Evaluation and Diagnosis of People With Pain and Fatigue Syndromes
Conditions: Fatigue;   Fibromyalgia;   Pain;   Complex Regional Pain Syndrome;   Reflex Sympathetic Dystrophy
Intervention:
11 Recruiting Screening Patients for NCI Protocol Eligibility
Conditions: Breast Cancer;   Prostate Cancer;   Lung Cancer;   Sarcoma;   Melanoma
Intervention:
12 Recruiting Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil
Condition: Bipolar Disorder
Interventions: Drug: Modafinil;   Drug: Placebo
13 Recruiting Screening for Childhood-Onset Psychotic Disorders
Conditions: Childhood Onset Psychotic Disorders;   Schizophrenia;   Psychosis;   Psychotic Disorder
Intervention:
14 Recruiting Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
Condition: Parasitic Disease
Intervention:
15 Recruiting Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products
Condition: Healthy Volunteers
Intervention:
16 Recruiting Screening Volunteers for Influenza Challenge Studies
Condition: Influenza, Human
Intervention:
17 Recruiting Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl Alone or in Combination With Ribavirin in Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Chlorcyclizine HCL plus Ribavirin;   Drug: Chlorcyclizine HCL Only
18 Recruiting Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in Cambodia
Condition: Acute Falciparum Malaria
Interventions: Drug: Dihydroartemisinin-piperaquine (DHA-PPQ);   Drug: Mefloquine (MQ)
19 Recruiting LMB-2 to Treat Hairy Cell Leukemia
Condition: Hairy Cell Leukemia
Intervention: Drug: Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
20 Recruiting Screening for Subjects to Participate in Studies of Blood Disorders
Conditions: Bone Marrow Transplant;   Sickle Cell Disease;   G-CSF
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years